Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ABBV-706 |
Trade Name | |
Synonyms | ABBV706|ABBV 706 |
Drug Descriptions |
ABBV-706 is an antibody-drug conjugate (ADC) comprising an antibody targeting SEZ6 linked to a topoisomerase I payload, which may have potential antitumor activity (Annals of Oncology 34 (2023): S1077, J Clin Oncol 42, 2024 (suppl 16; abstr 3001)). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C198215 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ABBV-706 | ABBV-706 | 0 | 1 |
ABBV-706 + Budigalimab | ABBV-706 Budigalimab | 0 | 1 |
ABBV-706 + Carboplatin | ABBV-706 Carboplatin | 0 | 1 |
ABBV-706 + Cisplatin | ABBV-706 Cisplatin | 0 | 1 |